Kojic acid is legal as a cosmetic ingredient in both the United States and the European Union, but the EU imposes a concentration restriction that US regulations do not, making market selection a critical formulation decision.
In the United States, the FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act. Kojic acid has no approved OTC monograph and is not a restricted ingredient under US cosmetic law. A face cream with kojic acid at any concentration used in a reasonable cosmetic context — without drug claims like 'treats melasma' — is lawful for US sale. The practical formulation ceiling is around 2% from an efficacy and sensitization risk standpoint, not a regulatory one.
In the European Union, the situation is more tightly defined. The SCCS evaluated kojic acid in 2021 (SCCS/1622/21) and deemed it safe at a maximum of 1% in face products and 0.5% in body/hand products for leave-on use. This assessment was incorporated into Annex III of EU Cosmetic Regulation 1223/2009, making 1% the hard ceiling for leave-on face creams sold across the EU and EEA. The same limits apply to Great Britain post-Brexit under OPSS oversight. Brands manufacturing above 1% for the US market and seeking EU expansion must reformulate — there is no waiver process.
From a safety science perspective, kojic acid at 0.5–1% is generally well tolerated. The primary adverse effects documented are contact sensitization and, at higher concentrations, erythema in sensitive skin types. Patch testing is advisable before regular use. Including a sensitization disclaimer in your product directions is good practice and may be required by some retail channels.
Transexamic acid has no regulatory restriction in either market when used as a cosmetic active (i.e., without a drug claim). It is not a known sensitizer at cosmetic use levels and has a clean safety profile at 2–5%.
For a brand planning simultaneous US and EU launch, the pragmatic formulation is 1% kojic acid and 3% tranexamic acid — fully compliant globally and clinically relevant in both markets. Cosmetic chemists connected through AJ Cosmo Labs routinely formulate for multi-market compliance from the first prototype.
Ingredients in this answer: Kojic Acid · Tranexamic Acid
Read the full guide on Private Label Tranexamic & Kojic Acid Face Cream Low MOQ →